Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00370_DB00752_nanopub.RA6mv342ejoHVRWatKQx-aDCWafO0UnxCs76TcMqFFN8U#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00370_DB00752 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00370_DB00752 label "DDI between Mirtazapine and Tranylcypromine - The MAO inhibitor, Tranylcypromine, may increase the central neurotoxic effects of the Mirtazapine. These agents should not be administered within 14 days of each other. [drugbank_resource:DB00370_DB00752]" assertion.
- drugbank_resource:DB00370_DB00752 identifier "drugbank_resource:DB00370_DB00752" assertion.
- drugbank_resource:DB00370_DB00752 title "DDI between Mirtazapine and Tranylcypromine - The MAO inhibitor, Tranylcypromine, may increase the central neurotoxic effects of the Mirtazapine. These agents should not be administered within 14 days of each other." assertion.
- drugbank:DB00370 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00370_DB00752 assertion.
- drugbank:DB00752 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00370_DB00752 assertion.